{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:28:10Z","timestamp":1787225290802,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471225-3247090211"],"award-info":[{"award-number":["32471225-3247090211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shanghai"},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75589-2","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:45:15Z","timestamp":1784087115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["G\u03b1q activation of free fatty acid receptor 4 suppresses metabolic dysfunction by disrupting Nr1h3-PPAR\u03b3 axis"],"prefix":"10.1038","volume":"17","author":[{"given":"Yulin","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-3173","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaopeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-2040","authenticated-orcid":false,"given":"Xuekui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4747-4708","authenticated-orcid":false,"given":"Yongquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4394-4274","authenticated-orcid":false,"given":"Xinmiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0145-7339","authenticated-orcid":false,"given":"Shenglong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"75589_CR1","doi-asserted-by":"publisher","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","volume":"160","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Global burden of metabolic diseases, 1990-2021. Metab. Clin. Exp. 160, 155999 (2024).","journal-title":"Metab. Clin. Exp."},{"key":"75589_CR2","doi-asserted-by":"publisher","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","volume":"384","author":"H Yao","year":"2024","unstructured":"Yao, H. et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ 384, e076410 (2024).","journal-title":"BMJ"},{"key":"75589_CR3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","volume":"79","author":"PN Newsome","year":"2023","unstructured":"Newsome, P. N. & Ambery, P. Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver. J. Hepatol. 79, 1557\u20131565 (2023).","journal-title":"J. Hepatol."},{"key":"75589_CR4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2337\/dci24-0003","volume":"47","author":"DJ Drucker","year":"2024","unstructured":"Drucker, D. J. Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity. Diab. Care 47, 1873\u20131888 (2024).","journal-title":"Diab. Care"},{"key":"75589_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543784.2013.839659","volume":"23","author":"JR Colca","year":"2014","unstructured":"Colca, J. R., Tanis, S. P., McDonald, W. G. & Kletzien, R. F. Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases. Expert Opin. Investig. Drugs 23, 1\u20137 (2014).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"75589_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd3777","volume":"11","author":"CC Blad","year":"2012","unstructured":"Blad, C. C., Tang, C. & Offermanns, S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat. Rev. Drug Discov. 11, 603\u2013619 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75589_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstr\u00f6m","year":"2008","unstructured":"Lagerstr\u00f6m, M. C. & Schi\u00f6th, H. B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339\u2013357 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75589_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2020","unstructured":"Kimura, I., Ichimura, A., Ohue-Kitano, R. & Igarashi, M. Free fatty acid receptors in health and disease. Physiol. Rev. 100, 171\u2013210 (2020).","journal-title":"Physiol. Rev."},{"key":"75589_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1124\/pr.112.007179","volume":"65","author":"AP Davenport","year":"2013","unstructured":"Davenport, A. P. et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol. Rev. 65, 967\u2013986 (2013).","journal-title":"Pharmacol. Rev."},{"key":"75589_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1006\/bbrc.1997.7513","volume":"239","author":"M Sawzdargo","year":"1997","unstructured":"Sawzdargo, M. et al. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem. Biophys. Res. Commun. 239, 543\u2013547 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75589_CR11","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. lipid Res. 54, 2325\u20132340 (2013).","journal-title":"J. lipid Res."},{"key":"75589_CR12","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3390\/nu7042839","volume":"7","author":"M Kasubuchi","year":"2015","unstructured":"Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A. & Kimura, I. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7, 2839\u20132849 (2015).","journal-title":"Nutrients"},{"key":"75589_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262\u20131267 (2012).","journal-title":"Science"},{"key":"75589_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/112_2013_13","volume":"164","author":"T Hara","year":"2013","unstructured":"Hara, T., Kimura, I., Inoue, D., Ichimura, A. & Hirasawa, A. Free fatty acid receptors and their role in regulation of energy metabolism. Rev. Physiol., Biochem. Pharmacol. 164, 77\u2013116 (2013).","journal-title":"Rev. Physiol., Biochem. Pharmacol."},{"key":"75589_CR15","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/mnfr.201300666","volume":"58","author":"F Rodriguez-Pacheco","year":"2014","unstructured":"Rodriguez-Pacheco, F. et al. Effects of obesity\/fatty acids on the expression of GPR120. Mol. Nutr. Food Res. 58, 1852\u20131860 (2014).","journal-title":"Mol. Nutr. Food Res."},{"key":"75589_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature10798","volume":"483","author":"A Ichimura","year":"2012","unstructured":"Ichimura, A. et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350\u2013354 (2012).","journal-title":"Nature"},{"key":"75589_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58706-5","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. FFAR4-mediated IL-6 release from islet macrophages promotes insulin secretion and is compromised in type-2 diabetes. Nat. Commun. 16, 3422 (2025).","journal-title":"Nat. Commun."},{"key":"75589_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41564-024-01902-8","volume":"10","author":"T Zhang","year":"2025","unstructured":"Zhang, T. et al. Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota. Nat. Microbiol. 10, 348\u2013361 (2025).","journal-title":"Nat. Microbiol."},{"key":"75589_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41392-022-01254-x","volume":"7","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. FFAR4 improves the senescence of tubular epithelial cells by AMPK\/SirT3 signaling in acute kidney injury. Signal Transduct. Target. Ther. 7, 384 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"75589_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj7813","volume":"10","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome. Sci. Adv. 10, eadj7813 (2024).","journal-title":"Sci. Adv."},{"key":"75589_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13543776.2020.1811852","volume":"30","author":"X Zhang","year":"2020","unstructured":"Zhang, X. & Macielag, M. J. GPR120 agonists for the treatment of diabetes: a patent review (2014 present). Expert Opin. Ther. Pat. 30, 729\u2013742 (2020).","journal-title":"Expert Opin. Ther. Pat."},{"key":"75589_CR22","doi-asserted-by":"crossref","unstructured":"Harrison, S. A. et al. A phase IIb randomised-controlled trial of the FFAR1\/FFAR4 agonist icosabutate in MASH. J. Hepatol.83, 293\u2013303 (2025).","DOI":"10.1016\/j.jhep.2025.01.032"},{"key":"75589_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6220","volume":"380","author":"C Mao","year":"2023","unstructured":"Mao, C. et al. Unsaturated bond recognition leads to biased signal in a fatty acid receptor. Science 380, eadd6220 (2023).","journal-title":"Science"},{"key":"75589_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.1995.75.1.47","volume":"75","author":"FB Hillgartner","year":"1995","unstructured":"Hillgartner, F. B., Salati, L. M. & Goodridge, A. G. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol. Rev. 75, 47\u201376 (1995).","journal-title":"Physiol. Rev."},{"key":"75589_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","volume":"64","author":"P Rinaldo","year":"2002","unstructured":"Rinaldo, P., Matern, D. & Bennett, M. J. Fatty acid oxidation disorders. Annu. Rev. Physiol. 64, 477\u2013502 (2002).","journal-title":"Annu. Rev. Physiol."},{"key":"75589_CR26","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Dimeric guaianolide sesquiterpenoids from the flowers of Chrysanthemum indicum ameliorate hepatic steatosis through mitigating SIRT1-mediated lipid accumulation and ferroptosis. J. Adv. Res.76, 345\u2013370 (2025).","DOI":"10.1016\/j.jare.2024.12.047"},{"key":"75589_CR27","doi-asserted-by":"publisher","first-page":"e2203286","DOI":"10.1002\/advs.202203286","volume":"9","author":"J Hong","year":"2022","unstructured":"Hong, J. & Kim, Y. H. Fatty liver\/adipose tissue dual-targeting nanoparticles with heme oxygenase-1 inducer for amelioration of obesity, obesity-induced type 2 diabetes, and steatohepatitis. Adv. Sci. 9, e2203286 (2022).","journal-title":"Adv. Sci."},{"key":"75589_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41418-018-0131-6","volume":"26","author":"Y Saito","year":"2019","unstructured":"Saito, Y. et al. DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9\/IFN-\u03b2 signaling pathway. Cell Death Differ. 26, 470\u2013486 (2019).","journal-title":"Cell Death Differ."},{"key":"75589_CR29","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cmet.2020.04.020","volume":"31","author":"VA Paschoal","year":"2020","unstructured":"Paschoal, V. A. et al. Positive reinforcing mechanisms between GPR120 and PPAR\u03b3 modulate insulin sensitivity. Cell Metab. 31, 1173\u20131188 (2020).","journal-title":"Cell Metab."},{"key":"75589_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2016.06.009","volume":"434","author":"T Song","year":"2016","unstructured":"Song, T. et al. GPR120 promotes adipogenesis through intracellular calcium and extracellular signal-regulated kinase 1\/2 signal pathway. Mol. Cell. Endocrinol. 434, 1\u201313 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"75589_CR31","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.08004","volume":"8","author":"A Majdalawieh","year":"2010","unstructured":"Majdalawieh, A. & Ro, H. S. PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nucl. Recept. Signal. 8, e004 (2010).","journal-title":"Nucl. Recept. Signal."},{"key":"75589_CR32","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.febslet.2014.05.012","volume":"588","author":"K Matsusue","year":"2014","unstructured":"Matsusue, K. et al. Hepatic PPAR\u03b3 and LXR\u03b1 independently regulate lipid accumulation in the livers of genetically obese mice. FEBS Lett. 588, 2277\u20132281 (2014).","journal-title":"FEBS Lett."},{"key":"75589_CR33","doi-asserted-by":"publisher","unstructured":"Grundmann, M., Bender, E., Schamberger, J. & Eitner, F. Pharmacology of free fatty acid receptors and their allosteric modulators. Int. J. Mol. Sci.22, https:\/\/doi.org\/10.3390\/ijms22041763 (2021).","DOI":"10.3390\/ijms22041763"},{"key":"75589_CR34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75589_CR35","volume":"6","author":"Z Bi","year":"2025","unstructured":"Bi, Z. et al. Emerging paradigms for target discovery of traditional medicines: A genome-wide pan-GPCR perspective. Innovation 6, 100774 (2025).","journal-title":"Innovation"},{"key":"75589_CR36","doi-asserted-by":"publisher","first-page":"108784","DOI":"10.1016\/j.pharmthera.2024.108784","volume":"266","author":"RL Teyani","year":"2025","unstructured":"Teyani, R. L. & Moniri, N. H. Biased agonism at free-fatty acid receptor-4 (FFA4\/GPR120). Pharmacol. Ther. 266, 108784 (2025).","journal-title":"Pharmacol. Ther."},{"key":"75589_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj2384","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Structural basis for the ligand recognition and signaling of free fatty acid receptors. Sci. Adv. 10, eadj2384 (2024).","journal-title":"Sci. Adv."},{"key":"75589_CR38","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41422-023-00835-x","volume":"33","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. Structural basis of omega-3 fatty acid receptor FFAR4 activation and G protein coupling selectivity. Cell Res. 33, 644\u2013647 (2023).","journal-title":"Cell Res."},{"key":"75589_CR39","doi-asserted-by":"publisher","first-page":"D395","DOI":"10.1093\/nar\/gkac1013","volume":"51","author":"G P\u00e1ndy-Szekeres","year":"2023","unstructured":"P\u00e1ndy-Szekeres, G. et al. GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources. Nucleic Acids Res. 51, D395\u2013d402 (2023).","journal-title":"Nucleic Acids Res."},{"key":"75589_CR40","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/prot.26382","volume":"90","author":"L Heo","year":"2022","unstructured":"Heo, L. & Feig, M. Multi-state modeling of G-protein coupled receptors at experimental accuracy. Proteins 90, 1873\u20131885 (2022).","journal-title":"Proteins"},{"key":"75589_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41586-025-09538-2","volume":"645","author":"T Hua","year":"2025","unstructured":"Hua, T. et al. Retraction Note: Crystal structures of agonist-bound human cannabinoid receptor CB(1). Nature 645, 544 (2025).","journal-title":"Nature"},{"key":"75589_CR42","doi-asserted-by":"publisher","unstructured":"Zhou, Q. et al. Common activation mechanism of class A GPCRs. eLife 8, https:\/\/doi.org\/10.7554\/elife.50279 (2019).","DOI":"10.7554\/elife.50279"},{"key":"75589_CR43","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1124\/mol.113.087783","volume":"84","author":"BD Hudson","year":"2013","unstructured":"Hudson, B. D. et al. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol. Pharmacol. 84, 710\u2013725 (2013).","journal-title":"Mol. Pharmacol."},{"key":"75589_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","volume":"117","author":"G Milligan","year":"2017","unstructured":"Milligan, G., Shimpukade, B., Ulven, T. & Hudson, B. D. Complex pharmacology of free fatty acid receptors. Chem. Rev. 117, 67\u2013110 (2017).","journal-title":"Chem. Rev."},{"key":"75589_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh, D. Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687\u2013698 (2010).","journal-title":"Cell"},{"key":"75589_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cmet.2012.04.009","volume":"15","author":"DY Oh","year":"2012","unstructured":"Oh, D. Y. & Olefsky, J. M. Omega 3 fatty acids and GPR120. Cell Metab. 15, 564\u2013565 (2012).","journal-title":"Cell Metab."},{"key":"75589_CR47","doi-asserted-by":"crossref","unstructured":"Tanaka, T. et al. Free fatty acids induce cholecystokinin secretion through GPR120.Naunyn Schmiedebergs. Arch. Pharmacol.377, 523\u2013527 (2008).","DOI":"10.1007\/s00210-007-0200-8"},{"key":"75589_CR48","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.2337\/db21-0794","volume":"71","author":"YQ Du","year":"2022","unstructured":"Du, Y. Q. et al. Endogenous lipid-GPR120 signaling modulates pancreatic islet homeostasis to different extents. Diabetes 71, 1454\u20131471 (2022).","journal-title":"Diabetes"},{"key":"75589_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1159\/000335820","volume":"28","author":"LM Cornall","year":"2011","unstructured":"Cornall, L. M., Mathai, M. L., Hryciw, D. H. & McAinch, A. J. Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner. Cell. Physiol. Biochem. 28, 949\u2013958 (2011).","journal-title":"Cell. Physiol. Biochem."},{"key":"75589_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2019.11.005","volume":"179","author":"KI Hilgendorf","year":"2019","unstructured":"Hilgendorf, K. I. et al. Omega-3 fatty acids activate ciliary FFAR4 to control adipogenesis. Cell 179, 1289\u20131305 (2019).","journal-title":"Cell"},{"key":"75589_CR51","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s00018-017-2492-2","volume":"74","author":"T Song","year":"2017","unstructured":"Song, T., Yang, Y., Zhou, Y., Wei, H. & Peng, J. GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue. Cell. Mol. life Sci. 74, 2723\u20132733 (2017).","journal-title":"Cell. Mol. life Sci."},{"key":"75589_CR52","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet, R. P. & Lay\u00e9, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 15, 771\u2013785 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"75589_CR53","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1002\/jcp.30204","volume":"236","author":"L Zhao","year":"2021","unstructured":"Zhao, L. et al. The roles of liver X receptor \u03b1 in inflammation and inflammation-associated diseases. J. Cell. Physiol. 236, 4807\u20134828 (2021).","journal-title":"J. Cell. Physiol."},{"key":"75589_CR54","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jhep.2014.07.025","volume":"61","author":"KT Chen","year":"2014","unstructured":"Chen, K. T. et al. Liver X receptor \u03b1 (LXR\u03b1\/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4\u03b1. J. Hepatol. 61, 1276\u20131286 (2014).","journal-title":"J. Hepatol."},{"key":"75589_CR55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1110\/ps.04951405","volume":"14","author":"L Yue","year":"2005","unstructured":"Yue, L. et al. Ligand-binding regulation of LXR\/RXR and LXR\/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation. Protein Sci. 14, 812\u2013822 (2005).","journal-title":"Protein Sci."},{"key":"75589_CR56","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1182\/blood-2010-09-306142","volume":"117","author":"M Spyridon","year":"2011","unstructured":"Spyridon, M. et al. LXR as a novel antithrombotic target. Blood 117, 5751\u20135761 (2011).","journal-title":"Blood"},{"key":"75589_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hep4.1453","volume":"4","author":"AM van den Hoek","year":"2020","unstructured":"van den Hoek, A. M. et al. Icosabutate exerts beneficial effects upon insulin sensitivity, hepatic inflammation, lipotoxicity, and fibrosis in mice. Hepatol. Commun. 4, 193\u2013207 (2020).","journal-title":"Hepatol. Commun."},{"key":"75589_CR58","doi-asserted-by":"crossref","unstructured":"Kasonga, A. E., Kruger, M. C. & Coetzee, M. Free fatty acid receptor 4-\u03b2-arrestin 2 pathway mediates the effects of different classes of unsaturated fatty acids in osteoclasts and osteoblasts. Biochim. Biophys. Acta Mol. Cell Biol. Lipids1864, 281\u2013289 (2019).","DOI":"10.1016\/j.bbalip.2018.12.009"},{"key":"75589_CR59","doi-asserted-by":"publisher","unstructured":"Ma, J. et al. Docosahexaenoic acid inhibits osteoclastogenesis via FFAR4-mediated regulation of inflammatory cytokines. Molecules30, https:\/\/doi.org\/10.3390\/molecules30153180 (2025).","DOI":"10.3390\/molecules30153180"},{"key":"75589_CR60","unstructured":"Semaglutide (Ozempic) for weight loss. Med. Lett. Drugs Ther.63, 53\u201354 (2021)."},{"key":"75589_CR61","doi-asserted-by":"publisher","first-page":"144423","DOI":"10.1016\/j.ijbiomac.2025.144423","volume":"315","author":"SC Kim","year":"2025","unstructured":"Kim, S. C., Gu, D. R., Yang, H., Lee, A. & Ha, H. Polysaccharides from Psoralea corylifolia seeds suppress osteoclastogenesis and alleviate osteoporosis. Int. J. Biol. Macromol. 315, 144423 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"75589_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbpa.2018.05.011","volume":"44","author":"H Mukherjee","year":"2018","unstructured":"Mukherjee, H. & Grimster, N. P. Beyond cysteine: recent developments in the area of targeted covalent inhibition. Curr. Opin. Chem. Biol. 44, 30\u201338 (2018).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"75589_CR63","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41557-025-01902-z","volume":"17","author":"PRA Zanon","year":"2025","unstructured":"Zanon, P. R. A. et al. Profiling the proteome-wide selectivity of diverse electrophiles. Nat. Chem. 17, 1712\u20131721 (2025).","journal-title":"Nat. Chem."},{"key":"75589_CR64","doi-asserted-by":"publisher","unstructured":"Huang, F., Han, X., Xiao, X. & Zhou, J. Covalent warheads targeting cysteine residue: the promising approach in drug development. Molecules27, https:\/\/doi.org\/10.3390\/molecules27227728 (2022).","DOI":"10.3390\/molecules27227728"},{"key":"75589_CR65","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbrc.2016.09.036","volume":"479","author":"K Griffett","year":"2016","unstructured":"Griffett, K. & Burris, T. P. Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease. Biochem. Biophys. Res. Commun. 479, 424\u2013428 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"75589_CR66","doi-asserted-by":"publisher","first-page":"110056","DOI":"10.1016\/j.biopha.2020.110056","volume":"126","author":"Z Huang","year":"2020","unstructured":"Huang, Z. et al. Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis. Biomed. Pharmacother. 126, 110056 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"75589_CR67","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/ijo.2016.37","volume":"40","author":"D Gozal","year":"2016","unstructured":"Gozal, D. et al. Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice. Int. J. Obes. 40, 1143\u20131149 (2016).","journal-title":"Int. J. Obes."},{"key":"75589_CR68","first-page":"3825","volume":"11","author":"F Dou","year":"2019","unstructured":"Dou, F. et al. Anti-atherosclerotic effects of LXR\u03b1 agonist through induced conversion of M1 macrophage to M2. Am. J. Transl. Res. 11, 3825\u20133840 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"75589_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116575","volume":"230","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Omega-3 polyunsaturated fatty acids alleviate hyperuricemic nephropathy by inhibiting renal pyroptosis through GPR120. Biochem. Pharmacol. 230, 116575 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"75589_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21623945.2021.2015864","volume":"11","author":"S Zhu","year":"2022","unstructured":"Zhu, S. et al. Adipose tissue plays a major role in retinoic acid-mediated metabolic homoeostasis. Adipocyte 11, 47\u201355 (2022).","journal-title":"Adipocyte"},{"key":"75589_CR71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12964-023-01297-9","volume":"21","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis. Cell Commun. Signal. 21, 268 (2023).","journal-title":"Cell Commun. Signal."},{"key":"75589_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11658-022-00314-y","volume":"27","author":"S Zhu","year":"2022","unstructured":"Zhu, S. et al. Slc25a5 regulates adipogenesis by modulating ERK signaling in OP9 cells. Cell. Mol. Biol. Lett. 27, 11 (2022).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"75589_CR73","doi-asserted-by":"publisher","first-page":"105173","DOI":"10.1016\/j.phrs.2020.105173","volume":"163","author":"F Xu","year":"2021","unstructured":"Xu, F. et al. Identification and target-pathway deconvolution of FFA4 agonists with anti-diabetic activity from Arnebia euchroma (Royle) Johnst. Pharmacol. Res. 163, 105173 (2021).","journal-title":"Pharmacol. Res."},{"key":"75589_CR74","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"75589_CR75","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.str.2012.04.010","volume":"20","author":"E Chun","year":"2012","unstructured":"Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967\u2013976 (2012).","journal-title":"Structure"},{"key":"75589_CR76","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","volume":"558","author":"A Koehl","year":"2018","unstructured":"Koehl, A. et al. Structure of the \u00b5-opioid receptor-G(i) protein complex. Nature 558, 547\u2013552 (2018).","journal-title":"Nature"},{"key":"75589_CR77","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-021-04077-y","volume":"600","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Structure, function and pharmacology of human itch receptor complexes. Nature 600, 164\u2013169 (2021).","journal-title":"Nature"},{"key":"75589_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"75589_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"75589_CR80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-024-07215-4","volume":"628","author":"K Jamali","year":"2024","unstructured":"Jamali, K. et al. Automated model building and protein identification in cryo-EM maps. Nature 628, 450\u2013457 (2024).","journal-title":"Nature"},{"key":"75589_CR81","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"75589_CR82","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1107\/S0907444909029436","volume":"65","author":"NW Moriarty","year":"2009","unstructured":"Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. Sect. D. Biol. Crystallogr. 65, 1074\u20131080 (2009).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"75589_CR83","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. D. Struct. Biol."},{"key":"75589_CR84","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1107\/S2059798318009324","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. Sect. D. Struct. Biol. 74, 814\u2013840 (2018).","journal-title":"Acta Crystallogr. Sect. D. Struct. Biol."},{"key":"75589_CR85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75589-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75589-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75589-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:03:05Z","timestamp":1787223785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75589-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75589"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75589-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8664"}}